As of Feb 17
| +0.38 / +0.36%|
The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 125.00, with a high estimate of 160.00 and a low estimate of 105.00. The median estimate represents a +18.25% increase from the last price of 105.71.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.